Rite Aid Latest Target Of Glucosamine False Ad Litigation

Law360, Chicago (November 27, 2013, 2:59 PM EST) -- A Staten Island man recently hit Rite Aid Corp. with a proposed class action in New York federal court, alleging the pharmacy chain falsely advertises that its store-brand glucosamine and chondroitin supplements can ease arthritis symptoms, despite overwhelming scientific evidence to the contrary.

The latest in a wave of lawsuits challenging the supplement’s effectiveness, Louis Lastres' Nov. 22 complaint takes issue with Rite Aid’s marketing that the supplements “help rebuild cartilage and lubricate joints.”

These claims are broadly targeted at anyone suffering from joint pain or...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Lastres v. Rite Aid Corporation


Case Number

1:13-cv-06550

Court

New York Eastern

Nature of Suit

Personal Inj. Prod. Liability

Judge

William F. Kuntz, II

Date Filed

November 25, 2013

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.